↓ Skip to main content

MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia

Overview of attention for article published in Frontiers in oncology, October 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
15 Mendeley